Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

OptiBiotix Health says SlimBiome to be used in Cereal Ingredients' Nutri-Bites range of cereal products

The AIM-listed obesity and cholesterol management company said that the partnership would extend the application of its SlimBiome® technology in breakfast cereals and bakery products
Measuring stomach
The product range will be showcased at the 2018 Natural Products Expo West & Engredea

OptiBiotix Health plc (LON:OPTI) has announced that its SlimBiome weight management technology will be used in US partner Cereal Ingredients' (CII) Nutri-Bites range of cereal products.

The AIM-listed obesity and cholesterol management firm said that the partnership will extend the application of SlimBiome® into products such as breakfast cereals and cookies, cakes as well as a range of healthy snacks, yoghurts, and cereal bars.

READ: OptiBiotix rises as its signs a production and commercialisation agreement

OptiBiotix said the move was a continuation of its focus on the US market following a supply and manufacturing agreement signed with CII in December 2017.

The group added that product range will be showcased at the 2018 Natural Products Expo West & Engredea, the world’s largest trade show for organic, natural and healthy products.

WATCH: Optibiotix to launch SlimBiome in Nutri-Bites with US partner

OptiBiotix's sales and marketing director, Christina Wood, said: “By combining OptiBiotix's award-winning SlimBiome® technology with CII's market-leading ingredients, manufacturing capacity and product development, we have created a delicious functional solution which can help customers manage their weight by reducing snacking and food intake without food cravings.

"We are delighted to share this innovative science-based approach to weight management with food and ingredient buyers from around the world at the Natural Products Expo West & Engredea show."

View full OPTI profile View Profile

OptiBiotix Health plc Timeline

Related Articles

1528305384_Untitled-design-(3).jpg
June 06 2018
Ventripoint received key FDA approval to sell the device with the four-chamber heart analysis last month
1527682514_angel-delight.jpg
May 30 2018
The latest fundraiser underscores the fact the life sciences business is well supported in the City
Harley Street sign
December 07 2017
The injection will bankroll the continuing technical development of the firm’s first LIGHT system and its installation at the Harley Street Proton Therapy Centre

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use